We are live on ! Find out more
PTJ

Paul Tudor Jones Tudor Investment Corp

AUM $71.9B
1-Year Est. Return 42.37%
 

Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.

This Fund
S&P 500
This Quarter Est. Return
+0.2%
1 Year Est. Return
+42.37%
3 Year Est. Return
+108.76%
5 Year Est. Return
+114.43%
10 Year Est. Return
+640.77%
AUM
$53.9B
AUM Growth
-$160M
Cap. Flow
+$2B
Cap. Flow %
3.72%
Top 10 Hldgs %
29.47%
Holding
4,438
New
1,030
Increased
1,219
Reduced
1,195
Closed
924

Sector Composition

Rank Sector Weight
1 Technology 5.79%
2 Financials 4.4%
3 Consumer Discretionary 3.69%
4 Industrials 3.64%
5 Healthcare 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPG icon
4126
PPG Industries
PPG
$25.3B
-27,883
Closed -$3.16M
PRAX icon
4127
CALL
Praxis Precision Medicines
PRAX
$10.5B
-2,100
Closed -$619K
PRAX icon
4128
Praxis Precision Medicines
PRAX
$10.5B
-16,009
Closed -$4.95M
PRCT icon
4129
CALL
Procept Biorobotics
PRCT
$1.24B
-12,000
Closed -$378K
PRCT icon
4130
PUT
Procept Biorobotics
PRCT
$1.24B
-10,100
Closed -$318K
PRG icon
4131
PROG Holdings
PRG
$1.54B
-26,381
Closed -$778K
PRI icon
4132
Primerica
PRI
$9.1B
-3,317
Closed -$857K
PRU icon
4133
CALL
Prudential Financial
PRU
$41.8B
-12,900
Closed -$1.46M
P
4134
CALL
Everpure Inc
P
$36.1B
-40,100
Closed -$2.69M
PTC icon
4135
PTC
PTC
$16.8B
-88,161
Closed -$15.4M
PTEN icon
4136
CALL
Patterson-UTI
PTEN
$4.71B
-650,000
Closed -$3.97M
PTGX icon
4137
Protagonist Therapeutics
PTGX
$9.99B
-7,718
Closed -$683K
QNST icon
4138
QuinStreet
QNST
$1.18B
-113,378
Closed -$1.63M
QQQM icon
4139
Invesco NASDAQ 100 ETF
QQQM
$103B
-6,997
Closed -$1.77M
QSR icon
4140
CALL
Restaurant Brands International
QSR
$28.2B
-4,800
Closed -$328K
QURE icon
4141
uniQure
QURE
$3.36B
-74,036
Closed -$1.5M
R icon
4142
Ryder
R
$9.58B
-1,604
Closed -$307K
RCL icon
4143
Royal Caribbean
RCL
$78.1B
-17,449
Closed -$5.2M
RDNT icon
4144
PUT
RadNet
RDNT
$6.05B
-5,700
Closed -$407K
REGN icon
4145
CALL
Regeneron Pharmaceuticals
REGN
$85.9B
-25,500
Closed -$19.7M
REKR icon
4146
CALL
Rekor Systems
REKR
$83.6M
-50,000
Closed -$69K
RELX icon
4147
RELX
RELX
$62.6B
-200,119
Closed -$8.09M
REPL icon
4148
Replimune Group
REPL
$1.39B
-128,380
Closed -$981K
REVG
4149
DELISTED
REV Group
REVG
-260,046
Closed -$15.8M
REX icon
4150
REX American Resources
REX
$1.47B
-84,640
Closed -$2.74M

Similar funds

Paul Tudor Jones's Q1 2026 Portfolio in Review

As of Q1 2026, Paul Tudor Jones held 4,438 positions worth $53.9B, down 0.3% from $54B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Paul Tudor Jones deployed $2B of net new capital in Q1 2026, opening 1,030 new positions and adding to 1,219 existing holdings. Its largest new stake was Warner Bros: 7,055,087 shares worth $194M.

By sector, the portfolio is most concentrated in Technology at 5.8% of assets, down from 6.3% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $821M trimmed.

  • Paul Tudor Jones's largest Q1 2026 buy was Warner Bros: 7,055,087 shares worth $194M.
  • Paul Tudor Jones added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $459M increase.
  • Paul Tudor Jones's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $821M.
  • Paul Tudor Jones fully exited Exact Sciences in Q1 2026, selling an estimated $201M.
  • Paul Tudor Jones's ten largest holdings make up 29% of its $53.9B portfolio in Q1 2026.
  • Paul Tudor Jones opened 1,030 new positions and closed 924 in Q1 2026.
  • Paul Tudor Jones's portfolio value fell 0.3% quarter-over-quarter to $53.9B.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.